Enzyme News and Research

RSS

Study highlights barriers to HIV care in sub-Saharan Africa

Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place.

23 Dec 2016

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to CYCLE Pharmaceuticals.

23 Dec 2016

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

An international team of scientists has discovered that the gene, OGDHL, a key protein required for normal function of the mitochondria -- the energy-producing factory of the cell -- and its chaperone, nardilysin (NRD1) are linked to progressive loss of neurological function in humans.

22 Dec 2016

Mount Sinai researchers laying groundwork to find effective treatment for Zika virus

Researchers at the Icahn School of Medicine at Mount Sinai are working on the basic science that lays the groundwork to finding a way to treat and prevent the Zika virus, a global health risk.

22 Dec 2016

Princeton researchers employ light to activate new reactivity in existing enzymes

Enzymes are nature's tools for catalyzing life's essential reactions. Though unrivaled in their efficiency and selectivity, enzymes only carry out a narrow range of natural reactions, limiting their usefulness in modern organic synthesis.

21 Dec 2016

Popular food supplement may be key in reversing detrimental effects of Familial Dysautonomia

A new Tel Aviv University study finds that a popular food supplement called phosphatidylserine may be instrumental in reversing the detrimental effects of Familial Dysautonomia (FD), a debilitating neurodegenerative disorder that affects approximately 1 in 31 Jewish people of Eastern European, or Ashkenazi, ancestry.

21 Dec 2016

Research sheds light on key genes essential to pathogenesis of Helicobacter pylori

Professor Frédéric Veyrier's most recent research, in collaboration with the team of Professor Hilde De Reuse at the Institut Pasteur, has shed light on key genes essential to the pathogenesis of Helicobacter pylori bacterium, which causes gastric infections.

21 Dec 2016

Research finds differences in cell migration between normal and malignant tumor cells

What makes cancer so deadly is its ability to move . The better that doctors can keep tumors contained and protect unaffected organs in the body, the less lethal a cancer will be.

21 Dec 2016

Researchers identify promising prospect for new medications to fight against H. pylori

There is a strong suspicion that Helicobacter pylori is linked to the development of stomach cancer. Now an international team of researchers led by Prof. Donald R. Ronning has used neutrons to unlock the secret to the functionality of an important enzyme in the bacterium's metabolism.

21 Dec 2016

‘Watershed in metabolon research’ unlocks plants' secret medicinal toolbox

Metabolons, near-mythical clusters of enzymes, have been discovered for the first time. Using fluorescent tags and microscopy -- molecular movie technology - scientists have confirmed their existence, thus unlocking plants' secret medicinal toolbox.

21 Dec 2016

Researchers creating computer model to track circadian clock

Biology dictates that DNA creates proteins which create - among other things - metabolites, the outputs of metabolism.

20 Dec 2016

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

Cilian AG, a biopharmaceutical company focused on the development of subunit vaccines, enzymes and monoclonal antibodies, announces that the European Journal of Gastroenterology & Hepatology, the international, peer-reviewed, online publication journal, has published an article entitled: Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.

20 Dec 2016

Enzyme News and Research

Study highlights barriers to HIV care in sub-Saharan Africa

Cycle Pharmaceuticals receives license for IP on PARP inhibitor drugs for treating vascular disease

Scientists discover OGDHL and NRD1 genes linked to progressive loss of neurological function

Mount Sinai researchers laying groundwork to find effective treatment for Zika virus

Princeton researchers employ light to activate new reactivity in existing enzymes

Popular food supplement may be key in reversing detrimental effects of Familial Dysautonomia

Research sheds light on key genes essential to pathogenesis of Helicobacter pylori

Research finds differences in cell migration between normal and malignant tumor cells

Researchers identify promising prospect for new medications to fight against H. pylori

‘Watershed in metabolon research’ unlocks plants' secret medicinal toolbox

Researchers creating computer model to track circadian clock

Leading journal publishes article about ciliate lipases as therapeutic candidates for oral treatment of EPI

Low-carbohydrate diet may help reverse inherited intellectual disability linked to Kabuki syndrome

Researchers use CRISPR-based genetic screening to identify three promising HIV treatment targets

Landmark clinical trial to test third investigational drug for Alzheimer's disease

Mayo Clinic scientists show how hungry liver cells find energy

FDA awards accelerated approval to new ovarian cancer drug

CNIC scientists reveal fundamental role of hypoxia response in correct formation of the heart

High levels of enzyme can predict memory impairment and Type 2 diabetes

Scientists discover mechanism that hijacks immune system's response to tuberculosis

Biochemical Assays for Efficient Hit Prioritization After Screening eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo